{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:22:28Z","timestamp":1793956948129,"version":"4.8.0"},"reference-count":118,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T00:00:00Z","timestamp":1659830400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01HD086062"],"award-info":[{"award-number":["R01HD086062"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01GM131398"],"award-info":[{"award-number":["R01GM131398"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"NSF","doi-asserted-by":"publisher","award":["DBI-1942143"],"award-info":[{"award-number":["DBI-1942143"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"NSF","doi-asserted-by":"publisher","award":["T32HD087166"],"award-info":[{"award-number":["T32HD087166"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Centers for Translational Research in Reproduction","award":["P50 HD071836"],"award-info":[{"award-number":["P50 HD071836"]}]},{"name":"Human Development","award":["P51 OD011092"],"award-info":[{"award-number":["P51 OD011092"]}]},{"DOI":"10.13039\/100008143","name":"Oregon National Primate Research Center","doi-asserted-by":"publisher","award":["P51 OD011092"],"award-info":[{"award-number":["P51 OD011092"]}],"id":[{"id":"10.13039\/100008143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000179","name":"Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In women, excess androgen causes polycystic ovary syndrome (PCOS), a common fertility disorder with comorbid metabolic dysfunctions including diabetes, obesity, and nonalcoholic fatty liver disease. Using a PCOS mouse model, this study shows that chronic high androgen levels cause hepatic steatosis while hepatocyte-specific androgen receptor (AR)-knockout rescues this phenotype. Moreover, through RNA-sequencing and metabolomic studies, we have identified key metabolic genes and pathways affected by hyperandrogenism. Our studies reveal that a large number of metabolic genes are directly regulated by androgens through AR binding to androgen response element sequences on the promoter region of these genes. Interestingly, a number of circadian genes are also differentially regulated by androgens. In vivo and in vitro studies using a circadian reporter [Period2::Luciferase (Per2::LUC)] mouse model demonstrate that androgens can directly disrupt the hepatic timing system, which is a key regulator of liver metabolism. Consequently, studies show that androgens decrease H3K27me3, a gene silencing mark on the promoter of core clock genes, by inhibiting the expression of histone methyltransferase, Ezh2, while inducing the expression of the histone demethylase, JMJD3, which is responsible for adding and removing the H3K27me3 mark, respectively. Finally, we report that under hyperandrogenic conditions, some of the same circadian\/metabolic genes that are upregulated in the mouse liver are also elevated in nonhuman primate livers. In summary, these studies not only provide an overall understanding of how hyperandrogenism associated with PCOS affects liver gene expression and metabolism but also offer insight into the underlying mechanisms leading to hepatic steatosis in PCOS.<\/jats:p>","DOI":"10.1210\/endocr\/bqac127","type":"journal-article","created":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T08:28:50Z","timestamp":1659860930000},"source":"Crossref","is-referenced-by-count":43,"title":["Androgen-mediated Perturbation of the Hepatic Circadian System Through Epigenetic Modulation Promotes NAFLD in PCOS Mice"],"prefix":"10.1210","volume":"163","author":[{"given":"Sambit","family":"Roy","sequence":"first","affiliation":[{"name":"Reproductive and Developmental Sciences Program, Department of Animal Science, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aierken","family":"Abudu","sequence":"additional","affiliation":[{"name":"Reproductive and Developmental Sciences Program, Department of Animal Science, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Salinas","sequence":"additional","affiliation":[{"name":"Reproductive and Developmental Sciences Program, Department of Animal Science, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika","family":"Sinha","sequence":"additional","affiliation":[{"name":"Reproductive and Developmental Sciences Program, Department of Animal Science, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Cline-Fedewa","sequence":"additional","affiliation":[{"name":"Reproductive and Developmental Sciences Program, Department of Animal Science, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M","family":"Yaw","sequence":"additional","affiliation":[{"name":"Reproductive and Developmental Sciences Program, Department of Animal Science, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A","family":"Lydic","sequence":"additional","affiliation":[{"name":"Collaborative Mass Spectrometry Core, Department of Physiology, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Cardiometabolic Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6760-3733","authenticated-orcid":false,"given":"Jon D","family":"Hennebold","sequence":"additional","affiliation":[{"name":"Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center , Beaverton, OR , USA"},{"name":"Department of Obstetrics & Gynecology, Oregon Health & Science University , Portland, OR , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne M","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Reproductive and Developmental Sciences Program, Department of Animal Science, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9290-4888","authenticated-orcid":false,"given":"Jianrong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Computational Mathematics, Science and Engineering, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8038-3715","authenticated-orcid":false,"given":"Aritro","family":"Sen","sequence":"additional","affiliation":[{"name":"Reproductive and Developmental Sciences Program, Department of Animal Science, Michigan State University , East Lansing, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"issue":"12","key":"2023080601472644700_CIT0001","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod."},{"issue":"1","key":"2023080601472644700_CIT0002","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril."},{"issue":"6","key":"2023080601472644700_CIT0003","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/cen.14098","article-title":"Prevalence of polycystic ovary syndrome in women with severe obesity\u2014effects of a structured weight loss programme","volume":"91","author":"Kataoka","year":"2019","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2023080601472644700_CIT0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"issue":"2","key":"2023080601472644700_CIT0005","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12020-014-0200-7","article-title":"Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome","volume":"47","author":"Livadas","year":"2014","journal-title":"Endocrine."},{"issue":"25","key":"2023080601472644700_CIT0006","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"issue":"1","key":"2023080601472644700_CIT0007","first-page":"89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2023080601472644700_CIT0008","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1210\/jcem.84.4.5591","article-title":"A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism","volume":"84","author":"Venturoli","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2023080601472644700_CIT0009","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1210\/jc.2006-2798","article-title":"Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial","volume":"92","author":"Calaf","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2023080601472644700_CIT0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/jcem.83.1.4500","article-title":"Hormonal effects of flutamide in young women with polycystic ovary syndrome","volume":"83","author":"De Leo","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2023080601472644700_CIT0011","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/09513590.2012.754876","article-title":"Ovulatory effects of flutamide in the polycystic ovary syndrome","volume":"29","author":"Paradisi","year":"2013","journal-title":"Gynecol Endocrinol."},{"issue":"16","key":"2023080601472644700_CIT0012","doi-asserted-by":"crossref","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","article-title":"Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome","volume":"114","author":"Caldwell","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"issue":"4","key":"2023080601472644700_CIT0013","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/en.2014-1887","article-title":"Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization","volume":"156","author":"Caldwell","year":"2015","journal-title":"Endocrinology."},{"issue":"5","key":"2023080601472644700_CIT0014","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev."},{"issue":"5","key":"2023080601472644700_CIT0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"26","key":"2023080601472644700_CIT0016","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3748\/wjg.v20.i26.8351","article-title":"Nonalcoholic fatty liver disease and polycystic ovary syndrome","volume":"20","author":"Vassilatou","year":"2014","journal-title":"World J Gastroenterol."},{"issue":"39","key":"2023080601472644700_CIT0017","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.3748\/wjg.v20.i39.14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"World J Gastroenterol."},{"issue":"1","key":"2023080601472644700_CIT0018","doi-asserted-by":"crossref","first-page":"e000352","DOI":"10.1136\/bmjgast-2019-000352","article-title":"Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"7","author":"Asfari","year":"2020","journal-title":"BMJ Open Gastroenterol."},{"issue":"11","key":"2023080601472644700_CIT0019","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"2023080601472644700_CIT0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod Health."},{"issue":"4","key":"2023080601472644700_CIT0021","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2023080601472644700_CIT0022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0974-1208.112370","article-title":"Prevalence of hepatic steatosis in women with polycystic ovary syndrome","volume":"6","author":"Karoli","year":"2013","journal-title":"J Hum Reprod Sci."},{"issue":"3","key":"2023080601472644700_CIT0023","doi-asserted-by":"crossref","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","journal-title":"PLoS Med."},{"issue":"1","key":"2023080601472644700_CIT0024","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","journal-title":"Hum Reprod."},{"issue":"12","key":"2023080601472644700_CIT0025","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J Endocrinol Invest."},{"issue":"10","key":"2023080601472644700_CIT0026","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2023080601472644700_CIT0027","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1038\/s41598-021-86697-y","article-title":"Non-alcoholic fatty liver disease in polycystic ovary syndrome women","volume":"11","author":"Won","year":"2021","journal-title":"Sci Rep."},{"issue":"9","key":"2023080601472644700_CIT0028","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int J Obes (Lond)."},{"key":"2023080601472644700_CIT0029","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DMSO.S146339","article-title":"Obesity and nonalcoholic fatty liver disease: current perspectives","volume":"11","author":"Sarwar","year":"2018","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"7","key":"2023080601472644700_CIT0030","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2007-0022","article-title":"Extranuclear steroid receptors: nature and actions","volume":"28","author":"Hammes","year":"2007","journal-title":"Endocr Rev."},{"issue":"2","key":"2023080601472644700_CIT0031","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yfrne.2007.10.005","article-title":"Non-genomic actions of androgens","volume":"29","author":"Foradori","year":"2008","journal-title":"Front Neuroendocrinol."},{"issue":"2","key":"2023080601472644700_CIT0032","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.yfrne.2007.08.004","article-title":"Rapid actions of androgens","volume":"29","author":"Michels","year":"2008","journal-title":"Front Neuroendocrinol."},{"issue":"9","key":"2023080601472644700_CIT0033","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1210\/en.2017-00145","article-title":"Androgens regulate ovarian gene expression through modulation of ezh2 expression and activity","volume":"158","author":"Ma","year":"2017","journal-title":"Endocrinology."},{"issue":"3","key":"2023080601472644700_CIT0034","doi-asserted-by":"crossref","first-page":"e1009483","DOI":"10.1371\/journal.pgen.1009483","article-title":"Androgens regulate ovarian gene expression by balancing Ezh2-Jmjd3 mediated H3K27me3 dynamics","volume":"17","author":"Roy","year":"2021","journal-title":"PLoS Genet."},{"issue":"8","key":"2023080601472644700_CIT0035","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1073\/pnas.1318978111","article-title":"Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression","volume":"111","author":"Sen","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"issue":"6","key":"2023080601472644700_CIT0036","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/en.2011-1754","article-title":"Reproductive and metabolic phenotype of a mouse model of PCOS","volume":"153","author":"van Houten","year":"2012","journal-title":"Endocrinology."},{"issue":"8","key":"2023080601472644700_CIT0037","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/en.2014-1196","article-title":"Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models","volume":"155","author":"Caldwell","year":"2014","journal-title":"Endocrinology."},{"issue":"7","key":"2023080601472644700_CIT0038","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1210\/me.2010-0006","article-title":"Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function","volume":"24","author":"Sen","year":"2010","journal-title":"Mol Endocrinol."},{"issue":"1","key":"2023080601472644700_CIT0039","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1074\/jbc.274.1.305","article-title":"Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase","volume":"274","author":"Postic","year":"1999","journal-title":"J Biol Chem."},{"issue":"1","key":"2023080601472644700_CIT0040","doi-asserted-by":"crossref","first-page":"17593","DOI":"10.1038\/s41598-020-74617-5","article-title":"HFD-induced hepatic lipid accumulation and inflammation are decreased in factor D deficient mouse","volume":"10","author":"Tsuru","year":"2020","journal-title":"Sci Rep."},{"issue":"8","key":"2023080601472644700_CIT0041","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1194\/jlr.D050302","article-title":"A monophasic extraction strategy for the simultaneous lipidome analysis of polar and nonpolar retina lipids","volume":"55","author":"Lydic","year":"2014","journal-title":"J Lipid Res."},{"issue":"41","key":"2023080601472644700_CIT0042","doi-asserted-by":"crossref","first-page":"27525","DOI":"10.1074\/jbc.M803867200","article-title":"Cross-talk between G protein-coupled and epidermal growth factor receptors regulates gonadotropin-mediated steroidogenesis in Leydig cells","volume":"283","author":"Evaul","year":"2008","journal-title":"J Biol Chem."},{"issue":"9","key":"2023080601472644700_CIT0043","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1210\/en.2018-00609","article-title":"Oocyte-derived factors (GDF9 and BMP15) and FSH regulate AMH expression via modulation of H3K27AC in granulosa cells","volume":"159","author":"Roy","year":"2018","journal-title":"Endocrinology."},{"issue":"5","key":"2023080601472644700_CIT0044","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/biolre\/ioaa007","article-title":"Developmental programming: prenatal testosterone-induced epigenetic modulation and its effect on gene expression in sheep ovarydagger","volume":"102","author":"Sinha","year":"2020","journal-title":"Biol Reprod."},{"key":"2023080601472644700_CIT0045"},{"key":"2023080601472644700_CIT0046"},{"key":"2023080601472644700_CIT0047"},{"key":"2023080601472644700_CIT0048"},{"key":"2023080601472644700_CIT0049"},{"key":"2023080601472644700_CIT0050"},{"key":"2023080601472644700_CIT0051"},{"key":"2023080601472644700_CIT0052","article-title":"Androgen-mediated perturbation of hepatic circadian system through epigenetic modulation promotes NAFLD in PCOS mice","author":"Roy","year":"2022","journal-title":"figshare."},{"issue":"7","key":"2023080601472644700_CIT0053","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1172\/JCI62044","article-title":"Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation","volume":"122","author":"Sen","year":"2012","journal-title":"J Clin Invest."},{"key":"2023080601472644700_CIT0054"},{"issue":"15","key":"2023080601472644700_CIT0055","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1073\/pnas.0308709101","article-title":"PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues","volume":"101","author":"Yoo","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"issue":"9","key":"2023080601472644700_CIT0056","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/humrep\/dex246","article-title":"Chronic combined hyperandrogenemia and Western-style diet in young female rhesus macaques causes greater metabolic impairments compared to either treatment alone","volume":"32","author":"True","year":"2017","journal-title":"Hum Reprod."},{"issue":"2","key":"2023080601472644700_CIT0057","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/humrep\/deaa321","article-title":"Individual and combined effects of 5-year exposure to hyperandrogenemia and Western-style diet on metabolism and reproduction in female rhesus macaques","volume":"36","author":"Bishop","year":"2021","journal-title":"Hum Reprod."},{"issue":"3","key":"2023080601472644700_CIT0058","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MED.0000000000000245","article-title":"Androgens in polycystic ovary syndrome: lessons from experimental models","volume":"23","author":"Walters","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"5","key":"2023080601472644700_CIT0059","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1095\/biolreprod.111.097808","article-title":"Rodent models for human polycystic ovary syndrome","volume":"86","author":"Walters","year":"2012","journal-title":"Biol Reprod."},{"issue":"3","key":"2023080601472644700_CIT0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.beem.2018.03.008","article-title":"Evidence from animal models on the pathogenesis of PCOS","volume":"32","author":"Walters","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"2023080601472644700_CIT0061","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome","author":"Stener-Victorin","year":"2020;41(4):010. :10.1210\/\/010","journal-title":"Endocr Rev."},{"issue":"6","key":"2023080601472644700_CIT0062","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.22252","article-title":"Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor","volume":"47","author":"Lin","year":"2008","journal-title":"Hepatology."},{"issue":"1","key":"2023080601472644700_CIT0063","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1038\/s41598-019-43928-7","article-title":"The differential expression of Cide family members is associated with Nafld progression from steatosis to steatohepatitis","volume":"9","author":"Sans","year":"2019","journal-title":"Sci Rep."},{"issue":"5","key":"2023080601472644700_CIT0064","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bcpt.13190","article-title":"A role of peroxisome proliferator-activated receptor gamma in non-alcoholic fatty liver disease","volume":"124","author":"Skat-Rordam","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"2023080601472644700_CIT0065","doi-asserted-by":"crossref","first-page":"30484","DOI":"10.1038\/srep30484","article-title":"Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL\/6J mice","volume":"6","author":"Rusli","year":"2016","journal-title":"Sci Rep."},{"key":"2023080601472644700_CIT0066","doi-asserted-by":"crossref","first-page":"601290","DOI":"10.3389\/fendo.2020.601290","article-title":"FGF21: an emerging therapeutic target for non-alcoholic steatohepatitis and related metabolic diseases","volume":"11","author":"Tillman","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"2023080601472644700_CIT0067","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1113\/JP277140","article-title":"Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions","volume":"597","author":"Orlicky","year":"2019","journal-title":"J Physiol."},{"issue":"43","key":"2023080601472644700_CIT0068","doi-asserted-by":"crossref","first-page":"30177","DOI":"10.1074\/jbc.M114.595850","article-title":"Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice","volume":"289","author":"Soufi","year":"2014","journal-title":"J Biol Chem."},{"issue":"1","key":"2023080601472644700_CIT0069","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/lt.25886","article-title":"Monoacylglycerol acyltransferase 1 knockdown exacerbates hepatic ischemia\/reperfusion injury in mice with hepatic steatosis","volume":"27","author":"Liss","year":"2021","journal-title":"Liver Transpl."},{"issue":"2","key":"2023080601472644700_CIT0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcmgh.2017.05.004","article-title":"Identification of the consistently altered metabolic targets in human hepatocellular carcinoma","volume":"4","author":"Nwosu","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol."},{"issue":"4","key":"2023080601472644700_CIT0071","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/hep.28953","article-title":"Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease","volume":"65","author":"Hall","year":"2017","journal-title":"Hepatology."},{"issue":"5","key":"2023080601472644700_CIT0072","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/hep.26060","article-title":"Disruption of the histidine triad nucleotide-binding hint2 gene in mice affects glycemic control and mitochondrial function","volume":"57","author":"Martin","year":"2013","journal-title":"Hepatology."},{"issue":"17","key":"2023080601472644700_CIT0073","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1089\/ars.2012.4946","article-title":"Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model","volume":"19","author":"Nabeshima","year":"2013","journal-title":"Antioxid Redox Signal."},{"issue":"12","key":"2023080601472644700_CIT0074","doi-asserted-by":"crossref","first-page":"R1053","DOI":"10.1152\/ajpregu.00066.2013","article-title":"Mechanism of the circadian clock in physiology","volume":"304","author":"Richards","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"5","key":"2023080601472644700_CIT0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.tem.2016.03.005","article-title":"Circadian system and glucose metabolism: implications for physiology and disease","volume":"27","author":"Qian","year":"2016","journal-title":"Trends Endocrinol Metab."},{"issue":"1","key":"2023080601472644700_CIT0076","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1152\/physrev.00016.2012","article-title":"Metabolism and the circadian clock converge","volume":"93","author":"Eckel-Mahan","year":"2013","journal-title":"Physiol Rev."},{"issue":"3","key":"2023080601472644700_CIT0077","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2015.11.043","article-title":"Circadian clock control of liver metabolic functions","volume":"150","author":"Reinke","year":"2016","journal-title":"Gastroenterology."},{"issue":"31","key":"2023080601472644700_CIT0078","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.3748\/wjg.v13.i31.4242","article-title":"Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease","volume":"13","author":"Sookoian","year":"2007","journal-title":"World J Gastroenterol."},{"key":"2023080601472644700_CIT0079","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-neuro-060909-153128","article-title":"Central and peripheral circadian clocks in mammals","volume":"35","author":"Mohawk","year":"2012","journal-title":"Annu Rev Neurosci."},{"issue":"4","key":"2023080601472644700_CIT0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrgastro.2016.8","article-title":"Circadian rhythms of liver physiology and disease: experimental and clinical evidence","volume":"13","author":"Tahara","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"12","key":"2023080601472644700_CIT0081","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cpcardiol.2005.07.002","article-title":"Sleep and cardiovascular disease","volume":"30","author":"Wolk","year":"2005","journal-title":"Curr Probl Cardiol."},{"issue":"12","key":"2023080601472644700_CIT0082","doi-asserted-by":"crossref","first-page":"e52983","DOI":"10.1371\/journal.pone.0052983","article-title":"Circadian clock genes Per1 and Per2 regulate the response of metabolism-associated transcripts to sleep disruption","volume":"7","author":"Husse","year":"2012","journal-title":"PLoS One."},{"issue":"9","key":"2023080601472644700_CIT0083","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2015-2123","article-title":"Androgen profile through life in women with polycystic ovary syndrome: a Nordic multicenter collaboration study","volume":"100","author":"Pinola","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2023080601472644700_CIT0084","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jc.2015-4009","article-title":"Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective","volume":"101","author":"Pasquali","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2023080601472644700_CIT0085","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/jc.2006-1327","article-title":"Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2023080601472644700_CIT0086","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2006-1191","article-title":"Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2023080601472644700_CIT0087","doi-asserted-by":"crossref","first-page":"e21921","DOI":"10.1096\/fj.202100961R","article-title":"Androgen-induced insulin resistance is ameliorated by deletion of hepatic androgen receptor in females","volume":"35","author":"Andrisse","year":"2021","journal-title":"FASEB J."},{"issue":"3","key":"2023080601472644700_CIT0088","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1210\/en.2016-1553","article-title":"Low-dose dihydrotestosterone drives metabolic dysfunction via cytosolic and nuclear hepatic androgen receptor mechanisms","volume":"158","author":"Andrisse","year":"2017","journal-title":"Endocrinology."},{"issue":"7","key":"2023080601472644700_CIT0089","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa061","article-title":"Androgen action in adipose tissue and the brain are key mediators in the development of PCOS traits in a mouse model","volume":"161","author":"Cox","year":"2020","journal-title":"Endocrinology."},{"issue":"1","key":"2023080601472644700_CIT0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2005.08.070","article-title":"Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice","volume":"336","author":"Inoue","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"issue":"2","key":"2023080601472644700_CIT0091","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","article-title":"Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis","volume":"134","author":"Zhou","year":"2008","journal-title":"Gastroenterology."},{"issue":"3","key":"2023080601472644700_CIT0092","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/aja.aja_19_19","article-title":"Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer","volume":"21","author":"Gritsina","year":"2019","journal-title":"Asian J Androl."},{"key":"2023080601472644700_CIT0093","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fphys.2019.00419","article-title":"FGF21 as modulator of metabolism in health and disease","volume":"10","author":"Tezze","year":"2019","journal-title":"Front Physiol."},{"key":"2023080601472644700_CIT0094","doi-asserted-by":"crossref","first-page":"153994","DOI":"10.1016\/j.metabol.2019.153994","article-title":"Fibroblast growth factor 21 in non-alcoholic fatty liver disease","volume":"101","author":"Tucker","year":"2019","journal-title":"Metabolism."},{"issue":"2","key":"2023080601472644700_CIT0095","first-page":"517","article-title":"Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance","volume":"86","author":"Vgontzas","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2023080601472644700_CIT0096","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/humrep\/det013","article-title":"Poor sleep in PCOS; is melatonin the culprit?","volume":"28","author":"Shreeve","year":"2013","journal-title":"Hum Reprod."},{"issue":"4","key":"2023080601472644700_CIT0097","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/0974-1208.126295","article-title":"Melatonin and its correlation with testosterone in polycystic ovarian syndrome","volume":"6","author":"Jain","year":"2013","journal-title":"J Hum Reprod Sci."},{"issue":"11","key":"2023080601472644700_CIT0098","doi-asserted-by":"crossref","first-page":"e112199e112199","DOI":"10.1371\/journal.pone.0112199","article-title":"A longitudinal assessment of sleep timing, circadian phase, and phase angle of entrainment across human adolescence","volume":"9","author":"Crowley","year":"2014","journal-title":"PLoS One."},{"key":"2023080601472644700_CIT0099","article-title":"Association between circadian rhythm disruption and polycystic ovary syndrome","author":"Wang","year":"2020","journal-title":"Fertil Steril."},{"key":"2023080601472644700_CIT0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.med.48.1.253","article-title":"Circadian rhythms: basic neurobiology and clinical applications","volume":"48","author":"Moore","year":"1997","journal-title":"Annu Rev Med."},{"issue":"2","key":"2023080601472644700_CIT0101","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tcb.2013.07.002","article-title":"Molecular architecture of the mammalian circadian clock","volume":"24","author":"Partch","year":"2014","journal-title":"Trends Cell Biol."},{"issue":"3","key":"2023080601472644700_CIT0102","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/oby.2007.118","article-title":"Short sleep duration and weight gain: a systematic review","volume":"16","author":"Patel","year":"2008","journal-title":"Obesity."},{"issue":"5","key":"2023080601472644700_CIT0103","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/sleep\/31.5.619","article-title":"Meta-analysis of short sleep duration and obesity in children and adults","volume":"31","author":"Cappuccio","year":"2008","journal-title":"Sleep."},{"issue":"8","key":"2023080601472644700_CIT0104","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-157-8-201210160-00005","article-title":"Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study","volume":"157","author":"Broussard","year":"2012","journal-title":"Ann Intern Med."},{"issue":"11","key":"2023080601472644700_CIT0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113943","article-title":"Disruption of circadian rhythms: a crucial factor in the etiology of infertility","volume":"21","author":"Sciarra","year":"2020","journal-title":"Int J Mol Sci ."},{"issue":"8","key":"2023080601472644700_CIT0106","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2018-02385","article-title":"Morning circadian misalignment is associated with insulin resistance in girls with obesity and polycystic ovarian syndrome","volume":"104","author":"Simon","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2023080601472644700_CIT0107","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2020.02.003","article-title":"Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome","volume":"219","author":"Li","year":"2020","journal-title":"Transl Res."},{"key":"2023080601472644700_CIT0108","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1038\/ncomms8231","article-title":"Circadian control of bile acid synthesis by a KLF15-Fgf15 axis","volume":"6","author":"Han","year":"2015","journal-title":"Nat Commun."},{"issue":"1","key":"2023080601472644700_CIT0109","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology."},{"issue":"9","key":"2023080601472644700_CIT0110","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.0611724104","article-title":"Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation","volume":"104","author":"Miller","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"issue":"3","key":"2023080601472644700_CIT0111","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nrg.2016.150","article-title":"Transcriptional architecture of the mammalian circadian clock","volume":"18","author":"Takahashi","year":"2017","journal-title":"Nat Rev Genet."},{"issue":"3","key":"2023080601472644700_CIT0112","doi-asserted-by":"crossref","first-page":"e1004155","DOI":"10.1371\/journal.pgen.1004155","article-title":"Genome-wide analysis of SREBP1 activity around the clock reveals its combined dependency on nutrient and circadian signals","volume":"10","author":"Gilardi","year":"2014","journal-title":"PLoS Genet."},{"issue":"8","key":"2023080601472644700_CIT0113","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/liv.12534","article-title":"Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity","volume":"34","author":"Mazzoccoli","year":"2014","journal-title":"Liver Int."},{"issue":"4","key":"2023080601472644700_CIT0114","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1095\/biolreprod.114.126409","article-title":"Developmental programming by androgen affects the circadian timing system in female mice","volume":"92","author":"Mereness","year":"2015","journal-title":"Biol Reprod."},{"key":"2023080601472644700_CIT0115","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-20-0578","article-title":"Androgen-induced epigenetic modulations in the ovary","author":"Salinas","year":"2021;249(3):53-64. :10.1530\/-20-0578","journal-title":"J Endocrinol."},{"issue":"4","key":"2023080601472644700_CIT0116","doi-asserted-by":"crossref","first-page":"e0174775","DOI":"10.1371\/journal.pone.0174775","article-title":"Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3","volume":"12","author":"Sherry-Lynes","year":"2017","journal-title":"PLoS One."},{"issue":"5","key":"2023080601472644700_CIT0117","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.devcel.2015.11.002","article-title":"Jmjd3-mediated H3K27me3 dynamics orchestrate brown fat development and regulate white fat plasticity","volume":"35","author":"Pan","year":"2015","journal-title":"Dev Cell."},{"issue":"12","key":"2023080601472644700_CIT0118","doi-asserted-by":"crossref","first-page":"24154","DOI":"10.3390\/ijms141224154","article-title":"EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD","volume":"14","author":"Vella","year":"2013","journal-title":"Int J Mol Sci ."}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqac127\/45286063\/bqac127.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/163\/10\/bqac127\/45598850\/bqac127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/163\/10\/bqac127\/45598850\/bqac127.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T21:50:04Z","timestamp":1691272204000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqac127\/6657796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":118,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqac127","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,8,6]]},"article-number":"bqac127"}}